| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $27,819,068 ) (Continued on the next page) |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL170607 | Mechanisms by which red blood cells contribute cardiopulmonary bypass associated inflammation | 000 | 3 | NIH | 3/9/2026 | $826,322 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL166317 | Unraveling a parabrachial circuit for the state-dependent control of rapid breathing | 001 | 4 | NIH | 3/25/2026 | $26,575 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL166317 | Unraveling a parabrachial circuit for the state-dependent control of rapid breathing | 000 | 4 | NIH | 3/5/2026 | $841,553 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD107794 | Randomized controlled trial of an internet-based prevention intervention for young children at-risk for functional abdominal pain | 000 | 5 | NIH | 4/1/2026 | $608,235 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD111410 | Development of a Multiplex Proteomics Assay for High-Throughput Newborn Screening of a New Set of Treatable Neonatal Diseases | 000 | 4 | NIH | 1/30/2026 | $568,132 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HD106628 | Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling | 000 | 5 | NIH | 3/3/2026 | $725,965 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01ES033785 | Assessing how Prenatal Phthalate Exposure Disrupts Placental Transcriptional Regulation and Contributes to Changes in Gestational Length | 000 | 4 | NIH | 12/9/2025 | $678,164 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DK136980 | Interrogating The Biology Of Human Lupus Nephritis Using Single Cell Resolution Spatial Transcriptomics | 000 | 3 | NIH | 1/20/2026 | $801,241 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01DE032663 | Influence of viral and immune interventions on early events following oral SIV infection | 000 | 4 | NIH | 12/12/2025 | $718,535 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01CA300296 | Menin and Ewing Sarcoma Metastasis | 000 | 1 | NIH | 3/30/2026 | $636,097 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01CA258866 | IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors | 001 | 5 | NIH | 2/19/2026 | $615,969 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI183642 | Targeted vaccines against pulmonary NTM infections in vulnerable populations | 000 | 2 | NIH | 1/3/2026 | $994,034 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI189738 | Impact of vaccination and preterm delivery on maternal RSV-specific peripheral and mucosal immunity | 000 | 1 | NIH | 2/20/2026 | $862,347 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI188789 | Species-transcending prevention of mosquito vector infection | 000 | 2 | NIH | 12/31/2025 | $808,475 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI180452 | Transporter function of the Mycobacterium tuberculosis PE/PPE proteins | 000 | 3 | NIH | 1/17/2026 | $856,417 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI177257 | Perturbations of host cell signaling by a complex hepatotropic pathogen | 000 | 14 | NIH | 1/14/2026 | $683,694 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI172824 | Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites | 000 | 4 | NIH | 1/16/2026 | $836,134 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI170914 | Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome | 000 | 4 | NIH | 1/22/2026 | $593,030 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI163160 | Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling | 000 | 5 | NIH | 1/22/2026 | $850,461 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI151167 | Manipulating alpha(v) integrins on B cells to promote lung-resident B cell responses | 000 | 5 | NIH | 3/27/2026 | $767,781 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI158536 | Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice | 000 | 5 | NIH | 3/20/2026 | $623,601 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI158536 | Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice | 001 | 5 | NIH | 4/2/2026 | $87,480 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AI132819 | Mechanisms of T Cell Quiescence and Exhaustion | 000 | 7 | NIH | 3/6/2026 | $645,962 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 001 | 4 | NIH | 2/25/2026 | $84,440 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 000 | 4 | NIH | 2/2/2026 | $759,966 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R00NS112575 | Dissecting the Action Learning Process with Dopaminergic Reinforcement | 000 | 5 | NIH | 3/5/2026 | $248,995 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R00CA263161 | Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia | 000 | 5 | NIH | 3/30/2026 | $248,977 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R00AI182458 | Elucidating a novel respiratory-mammary axis of T cell immunity | 000 | 3 | NIH | 4/2/2026 | $248,984 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K99AI182458 | Elucidating a novel respiratory-mammary axis of T cell immunity | 000 | 2 | NIH | 1/29/2026 | $34,331 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K24AR085177 | Mentoring the next generation of researchers in pediatric autoimmunity | 000 | 2 | NIH | 1/13/2026 | $211,662 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K01AI187782 | Mechanisms of Innate Immune Activation in Mitochondrial Disease Onset and Progression | 000 | 2 | NIH | 1/10/2026 | $122,562 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K08AI166072 | Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granuloma | 000 | 5 | NIH | 1/28/2026 | $183,968 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K01MD019730 | Extreme weather and mental health content on social media: Promoting racial and ethnic minority youth psychosocial resilience | 000 | 4 | NIH | 2/15/2026 | $127,370 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | K01DA058543 | Dissociating respiratory depression and analgesia via a data-driven model of interacting respiratory and pain networks | 000 | 4 | NIH | 3/19/2026 | $100,975 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $485,034 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 10 | 8 | HRSA | 3/17/2026 | $862,616 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 2/13/2026 | $0 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 2/13/2026 | $0 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 08 | 8 | HRSA | 12/1/2025 | $940,292 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 08 | 8 | HRSA | 12/1/2025 | $1,672,276 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U01DA060443 | Deep Analysis of Transcriptome to Understand the Genetics of Substance Use Disorders in Rats | 000 | 2 | NIH | 3/27/2026 | $882,279 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | U01AI165455 | Collective Responses to Malaria Vaccination | 000 | 5 | NIH | 1/20/2026 | $700,000 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R50CA275857 | Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials | 000 | 4 | NIH | 4/1/2026 | $175,338 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R37CA266777 | The IL-18-IFNγ axis predicts response to immunotherapy | 000 | 4 | NIH | 1/29/2026 | $714,132 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R25NS141155 | Summer Undergraduate Program to Advance Research and Quality in Pain and Neurological Health | 000 | 2 | NIH | 2/24/2026 | $129,113 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01MH123442 | Advancing Suicide Intervention Strategies for Teens During High Risk Periods | 000 | 5 | NIH | 1/22/2026 | $851,602 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01MH135568 | Atypical Development in Infants and Toddlers: Computational Attentional Signatures through Mobile Eye Tracking | 000 | 3 | NIH | 12/23/2025 | $880,471 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01HL163103 | Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy | 000 | 4 | NIH | 2/27/2026 | $740,074 |
| | 2026 | 2026 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3901 | KING | USA | R01MH113545 | Investigating the synaptic pathology of Autism | 000 | 9 | NIH | 12/12/2025 | $778,237 |
|
